Ignite Creation Date:
2025-12-25 @ 1:44 AM
Ignite Modification Date:
2025-12-26 @ 12:54 AM
Study NCT ID:
NCT05985694
Status:
COMPLETED
Last Update Posted:
2025-09-10
First Post:
2023-07-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
AD17002 Treating Poorly Controlled, Moderate to Severe Eosinophilic Asthma
Sponsor:
Advagene Biopharma Co. Ltd.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ADV_Asthma_17002-1
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |